Study-level factors associated with hematoma after ultrasound-guided vacuum-assisted breast lesion excision: a systematic review and meta-analysis using a T-P-B framework - Scorecard - MDSpire
Advertisement
Study-level factors associated with hematoma after ultrasound-guided vacuum-assisted breast lesion excision: a systematic review and meta-analysis using a T-P-B framework
Clinical Scorecard: Factors at the Study Level Linked to Hematoma Development Following Ultrasound-Guided Vacuum-Assisted Excision of Breast Lesions: A Systematic Review and Meta-Analysis Utilizing a T-P-B Framework
At a Glance
Category
Detail
Condition
Postoperative hematoma after ultrasound-guided vacuum-assisted breast lesion excision
Key Mechanisms
Tumor-related, position-related, and breast- or peri-procedural management-related factors
Target Population
Patients undergoing vacuum-assisted breast lesion excision
Care Setting
Clinical practice involving ultrasound-guided procedures
Key Highlights
Meta-analysis included 11 studies with 3,516 patients and 444 cases of hematoma.
Significant factors associated with hematoma include tumor numbers and cutting passes.
Non-moderate tumor depth and higher vascularity grade linked to increased hematoma risk.
Postoperative compression duration of less than 48 hours is a risk factor for hematoma.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
Postoperative hematoma is a common complication after VAE.
Incidence of hematoma after VABB/VAE is approximately 9%.
Patient & Prescribing Data
Patients undergoing VAE using a VABB system
Most postoperative hematomas are mild or moderate and can be managed conservatively.
Clinical Best Practices
Consider tumor numbers and cutting passes during risk assessment.
Evaluate tumor depth and vascularity grade as part of pre-procedural planning.
Ensure postoperative compression duration is adequate to minimize hematoma risk.
